The Government's administration of the Pharmaceutical Benefits Scheme

The Government's administration of the Pharmaceutical Benefits Scheme

17 August 2011

© Commonwealth of Australia 2011
ISBN 978-1-74229-511-4

View the report as a single document - (PDF 522KB)


View the report as separate downloadable parts:

Spacer Image
MEMBERSHIP OF THE COMMITTEE (PDF 11KB)
 
ABBREVIATIONS (PDF 11KB)
 
RECOMMENDATIONS (PDF 16KB)
 
Chapter 1 - Introduction (PDF 14KB)

Terms of reference
Conduct of the inquiry
Acknowledgement
Note on references
Structure of the report
Personal comment from the Chair - Declaration of interest

 
Chapter 2 - Background (PDF 43KB)

The Pharmaceutical Benefits Scheme
Memorandum of Understanding between the Commonwealth Government and Medicines Australia
Announcement of listing deferrals

 
Chapter 3 - The Government's decision to defer the listing of medicines under the Pharmaceutical Benefits Scheme (PDF 91KB)

Introduction
The change to the administration of the PBS
Impact of the change to the administration of the PBS
Compliance with the intent of the Memorandum of Understanding
Lack of consultation

 
Chapter 4 - Financial impact of the Pharmaceutical Benefits Scheme on the Commonwealth Budget (PDF 62KB)

Introduction
Overall costs and growth of the PBS
Financial impact of the Government decision to defer listings
Other possible savings measures

 
Chapter 5 - Consequences for patients (PDF 125KB)

Introduction
Financial impost
Access to medicines
Impact on health outcomes
Benefits of effective treatment of medical conditions
Consequences of not having access to the deferred medicines
Committee comment

 
Chapter 6 - Consequences for the pharmaceutical sector and the availability of medicines in Australia (PDF 77KB)

Introduction
Consequences for companies
Consequences for research and development
Consequences for the availability of medicines in the Australian market

 
Chapter 7 - Conclusions and recommendations (PDF 22KB)
 
Government senator's minority report (PDF 60KB)

Introduction
Process of listing medicines on the PBS
Financial impact on the Commonwealth budget
The Memorandum of Understanding with Medicines Australia
A healthy pharmaceutical sector
The Australian medicines market - available and accessible medicines
Government senator's view

 
Australian Greens Additional Comments (PDF 16KB)

Introduction
Achieving lower priced generic medicines
Evergreening of patents by originator companies
Savings from change of prescriber habits

 
APPENDIX 1 - Submissions and additional information received by the committee (PDF 11KB)

Submissions
Additional information received

 
APPENDIX 2 - Public hearings and witnesses (PDF 8KB)

For further information, contact:

Committee Secretary
Senate Standing Committees on Finance and Public Administration
PO Box 6100
Parliament House
Canberra ACT 2600
Australia

Phone: +61 2 6277 3439
Fax: +61 2 6277 5809
Email: fpa.sen@aph.gov.au

 

Top